These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 33729859)
1. The role of peroxisome proliferator-activated receptor gamma and adiponectin in children with Kawasaki disease. Zhang JY; Peng H; Gong ST; Zeng YM; Huang M; Liu PH; Wang LT; Dong GQ J Int Med Res; 2021 Mar; 49(3):300060521994925. PubMed ID: 33729859 [TBL] [Abstract][Full Text] [Related]
2. Imbalance of peroxisome proliferator-activated receptor gamma and adiponectin predisposes Kawasaki disease patients to developing atherosclerosis. Fukunaga H; Kishiro M; Akimoto K; Ohtsuka Y; Nagata S; Shimizu T Pediatr Int; 2010 Oct; 52(5):795-800. PubMed ID: 20487372 [TBL] [Abstract][Full Text] [Related]
3. [Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide]. Huiling L; Yaping L; Xiufen H Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):300-3. PubMed ID: 26182507 [TBL] [Abstract][Full Text] [Related]
4. [Serum adiponectin levels in children with Kawasaki disease]. Huang M; Dong GQ; Jiang HY; Zhang JY; Shi XJ Zhongguo Dang Dai Er Ke Za Zhi; 2015 Jan; 17(1):35-9. PubMed ID: 25616290 [TBL] [Abstract][Full Text] [Related]
5. [Role of ash2 (absent, small, or homeotic)-like and Jumonji domain-containing protein 3 on histone methylation of interferon-gamma gene and their associations with vascular damage of Kawasaki disease]. Mei JH; Tang G; Wang Q; Wen PQ; Xu MG; Cui D; Ma DL; Liu C; Wang GB Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Sep; 45(9):791-798. PubMed ID: 29036979 [No Abstract] [Full Text] [Related]
6. [Changes of P-selectin and E-selectin in children with Kawasaki disease]. Qiu Y; Wu J; Fang XY; Lin Z; Wu BY; Cai RY; Xu XY; Zheng H Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):688-92. PubMed ID: 15482673 [TBL] [Abstract][Full Text] [Related]
7. [Serum levels of interleukin-38 and interleukin-1β in the acute phase of Kawasaki disease in children]. Zhang XY; He T; Ling JY; Hu XF; Wen Y; Wei J; Lu HL Zhongguo Dang Dai Er Ke Za Zhi; 2018 Jul; 20(7):543-548. PubMed ID: 30022755 [TBL] [Abstract][Full Text] [Related]
8. Association between adropin and coronary artery lesions in children with Kawasaki disease. Yang M; Pei Q; Zhang J; Weng H; Jing F; Yi Q Eur J Pediatr; 2021 Jul; 180(7):2253-2259. PubMed ID: 33712900 [TBL] [Abstract][Full Text] [Related]
9. Expression of FcRs on monocytes among Kawasaki disease patients with coronary artery lesions. Xia Y; Tian X; Li Q; Wang G; Li C; Yang J Int Immunopharmacol; 2017 Apr; 45():1-5. PubMed ID: 28147297 [TBL] [Abstract][Full Text] [Related]
10. [Changes and significance of oxidized phospholipids and endothelial nitric oxide synthase in the acute stage of Kawasaki disease]. Zhu LR; He XH; Yuan YH; Yuan H; Xia XH Zhongguo Dang Dai Er Ke Za Zhi; 2024 Aug; 26(8):829-834. PubMed ID: 39148387 [TBL] [Abstract][Full Text] [Related]
11. Plasma H2S predicts coronary artery lesions in children with Kawasaki disease. Sun Y; Yuan Y; Yan H; Wan H; Li X; Chen S; Li H; Tang C; Du J; Liu G; Jin H Pediatr Int; 2015 Oct; 57(5):840-4. PubMed ID: 25808254 [TBL] [Abstract][Full Text] [Related]
12. Expression of PCT, BNP and Inflammatory Factors in Children with Kawasaki Disease and Their Correlation with Coronary Artery Lesions. Feng H; Chai H; Li D; Shi C; Xu Y; Liu Y Altern Ther Health Med; 2024 Jan; 30(1):302-306. PubMed ID: 37820655 [TBL] [Abstract][Full Text] [Related]
13. Red blood cell distribution width and tumor necrosis factor-α for the early prediction of coronary artery lesion in Kawasaki disease: a retrospective study. Li J; Li DE; Hu M; Huang H; Xu S; Li H Eur J Pediatr; 2022 Mar; 181(3):903-909. PubMed ID: 34494160 [TBL] [Abstract][Full Text] [Related]
14. [Matrix metalloproteinase-1 expression in the circulation of patients with Kawasaki disease and its role in the pathogenesis of coronary artery lesions]. Yang SW; Wang DW; Li J; Qin YM; Wang FM; Cao LM; Zhang LF; Hu Z Zhonghua Er Ke Za Zhi; 2005 Aug; 43(8):612-5. PubMed ID: 16191276 [TBL] [Abstract][Full Text] [Related]
15. Analysis of Risk Factors for Coronary Artery Lesion in Children with Kawasaki Disease. Bai B; Ya JL; Yan C J Coll Physicians Surg Pak; 2022 Aug; 32(8):1037-1041. PubMed ID: 35932129 [TBL] [Abstract][Full Text] [Related]
16. [Association of rs4638289 and rs7131332 polymorphisms of the serum amyloid A1 gene with Kawasaki disease]. Chen Y; Wang C; Ji Q; Zhang J; Tan C; Wang SS; Yi XY Zhongguo Dang Dai Er Ke Za Zhi; 2020 Jun; 22(6):614-619. PubMed ID: 32571461 [TBL] [Abstract][Full Text] [Related]
17. Predictive value of heart rate deceleration capacity on coronary artery lesion in acute phase of Kawasaki disease. Lu Y; Guo Y; Si F; Chen T; Jin M; Wen Y; Wang X Sci Rep; 2020 Jun; 10(1):10211. PubMed ID: 32576944 [TBL] [Abstract][Full Text] [Related]
18. [Relationship between heart rate variability and coronary artery lesion in children with Kawasaki disease]. Chen TT; Shi K; Liu YL; Guo YH; Li Y; Wang XM Zhongguo Dang Dai Er Ke Za Zhi; 2015 Jun; 17(6):607-12. PubMed ID: 26108324 [TBL] [Abstract][Full Text] [Related]
19. Clinical manifestations and risk factors of coronary artery lesions in children with Kawasaki disease. Wang L; Zeng X; Chen B Medicine (Baltimore); 2023 Sep; 102(37):e34939. PubMed ID: 37713854 [TBL] [Abstract][Full Text] [Related]
20. [Changes in 25-hydroxyvitamin D3 level and its significance in children with Kawasaki disease]. Zhang YD; Li RM; Ji CY; Zhang XL; Zhang Y; Dong QW; Ma L Zhongguo Dang Dai Er Ke Za Zhi; 2016 Mar; 18(3):211-4. PubMed ID: 26975816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]